Chemoinformaics analysis of TASHIRONIN A
Molecular Weight | 390.476 | nRot | 2 |
Heavy Atom Molecular Weight | 360.236 | nRig | 23 |
Exact Molecular Weight | 390.204 | nRing | 6 |
Solubility: LogS | -4.042 | nHRing | 1 |
Solubility: LogP | 2.476 | No. of Aliphatic Rings | 6 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 22 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 61.5558 |
nHD | 2 | BPOL | 35.3042 |
QED | 0.703 |
Synth | 6.745 |
Natural Product Likeliness | 2.694 |
NR-PPAR-gamma | 0.047 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.04 |
Pgp-sub | 0.689 |
HIA | 0.039 |
CACO-2 | -5.171 |
MDCK | 0.0000278 |
BBB | 0.996 |
PPB | 0.723095 |
VDSS | 0.898 |
FU | 0.256203 |
CYP1A2-inh | 0.031 |
CYP1A2-sub | 0.936 |
CYP2c19-inh | 0.425 |
CYP2c19-sub | 0.851 |
CYP2c9-inh | 0.32 |
CYP2c9-sub | 0.05 |
CYP2d6-inh | 0.086 |
CYP2d6-sub | 0.108 |
CYP3a4-inh | 0.663 |
CYP3a4-sub | 0.686 |
CL | 5.766 |
T12 | 0.101 |
hERG | 0.024 |
Ames | 0.483 |
ROA | 0.92 |
SkinSen | 0.061 |
Carcinogencity | 0.898 |
EI | 0.01 |
Respiratory | 0.9 |
NR-Aromatase | 0.878 |
Antiviral | Yes |
Prediction | 0.687487 |